2. Academic Validation
  3. Zhichuanling oral liquid attenuates airway inflammation in asthma by targeting the STIM1/CHOP/JNK axis

Zhichuanling oral liquid attenuates airway inflammation in asthma by targeting the STIM1/CHOP/JNK axis

  • J Ethnopharmacol. 2026 Feb 10:356:120859. doi: 10.1016/j.jep.2025.120859.
Huidan Chen 1,  Sihui Xing 2,  Jiaqi Wu 3,  Yue Li 4,  Xia Yang 5,  Zhongtian Wang 6,  Jinpu Zhu 7,  Siye Lv 8,  Shangge Xu 9,  Yilong Zhu 10,  Liping Sun 11
Affiliations

Affiliations

  • 1 College of Chinese Medicine, Changchun University of Chinese Medicine, Changchun, China. Electronic address: HD13578889182@163.com.
  • 2 College of Chinese Medicine, Changchun University of Chinese Medicine, Changchun, China. Electronic address: 17808071164@163.com.
  • 3 Foshan Women and Children's Hospital, Foshan, China. Electronic address: 836193949@qq.com.
  • 4 Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China. Electronic address: 1594391973@qq.com.
  • 5 Department of Pathology and Pathophysiology, College of Medicine, Yanbian University, Yanji, China. Electronic address: 1669554669@qq.com.
  • 6 College of Chinese Medicine, Changchun University of Chinese Medicine, Changchun, China. Electronic address: wztccucm@163.com.
  • 7 College of Chinese Medicine, Changchun University of Chinese Medicine, Changchun, China. Electronic address: 605847356@qq.com.
  • 8 College of Chinese Medicine, Changchun University of Chinese Medicine, Changchun, China. Electronic address: 576616756@qq.com.
  • 9 Department of Pediatrics, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China. Electronic address: joanna_1000@163.com.
  • 10 College of Chinese Medicine, Changchun University of Chinese Medicine, Changchun, China; Key Laboratory of Jilin Province for Traditional Chinese Medicine Prevention and Treatment of Infectious Diseases, College of Integrative Medicine, Changchun University of Chinese Medicine, Changchun, China. Electronic address: zhuyilong66@163.com.
  • 11 College of Chinese Medicine, Changchun University of Chinese Medicine, Changchun, China; Center of Traditional Chinese Medicine, The Affliated Hospital to Changchun University of Chinese Medicine, Changchun, China. Electronic address: slpwzt7063@163.com.
PMID: 41197928 DOI: 10.1016/j.jep.2025.120859
Abstract

Ethnopharmacological relevance: Zhichuanling oral liquid (ZCLOL) is a multi-component traditional Chinese medicine formulation that has been widely used in the clinical management of asthma. However, the molecular mechanisms underlying its clinical efficacy remain largely undefined, particularly regarding calcium homeostasis and endoplasmic reticulum stress (ERS) regulation.

Aim of the study: This study aimed to elucidate the mechanisms by which ZCLOL mitigates asthma-related airway inflammation through the integration of in vivo and in vitro models with proteomic profiling.

Methods: In this study, an OVA-induced asthma model was established to evaluate the therapeutic effects of ZCLOL by assessing pulmonary function, serum Th2 cytokine levels, and macrophage polarization. To further elucidate the underlying mechanisms of ZCLOL in asthma treatment, we conducted proteomic analysis, measured calcium levels in lung tissue, and performed Western blotting. Additionally, an inflammatory BEAS-2B cell model induced by LPS and IL-13, combined with BAPTA-AM treatment, was used to explore the molecular pathways involved.

Results: ZCLOL effectively alleviated airway hyperresponsiveness, reduced lung tissue injury, inhibited M1 macrophage polarization and Th2 cytokine secretion, decreased intracellular calcium ion levels, mitigated endoplasmic reticulum stress, and downregulated the expression of STIM1, Bip, Ero1-Lα, PDI, CHOP, and phosphorylated JNK (p-JNK).

Conclusion: ZCLOL alleviates airway inflammation and hyperresponsiveness in asthma by restoring CA2+ homeostasis and suppressing ERS through inhibition of the STIM1/CHOP/JNK axis. These findings provide mechanistic evidence supporting ZCLOL as a potential multi-target therapeutic strategy for asthma.

Keywords

Airway inflammation; Asthma; Proteomics; STIM1/CHOP/JNK axis; Zhichuanling oral liquid.

Figures
Products
Inhibitors & Agonists
Other Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z